Navigation Links
Ohr Pharmaceutical Announces $5 Million Financing from Exercise of Warrants
Date:4/22/2013

NEW YORK, April 22, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs, today announced that Ohr raised approximately $5.05 million dollars from institutional and accredited shareholders through the exercise of Series B Warrants.  The Company intends to use the net proceeds from this offering to complete its Phase II Squalamine eye drop clinical trial for the wet form of age-related macular degeneration, further the clinical development of Squalamine eye drops for the treatment of other neovascular ophthalmic disorders, fund continued development of other pipeline molecules, and for general corporate purposes.

"The Company's ability to raise significant capital on favorable terms and provide itself with a cash runway into 2015 is a confirmation of the continued progress on the Company's clinical development programs," said Ira Greenstein , Chairman of the Board of Directors. "The additional capital will allow us to continue to execute on the Company's strategy and increases shareholder equity, one of the requirements for our proposed uplisting to Nasdaq."

"We would like to thank our shareholders for their continued support," said Dr. Irach B. Taraporewala, CEO of Ohr Pharmaceutical. "I am pleased to report that we anticipate completing 50% enrollment in the Phase II Squalamine eye drop trial midyear and look forward to continuing to update shareholders on the progress of our clinical trial and business initiatives."   

About the Warrant Exercise

On April 5, 2013, the Company gave notice to Series B Warrant holders that the Company was opting to accelerate the expiration date of the Series B Warrants to April 18, 2013. Additionally, as an incentive to encourage exercise of the Series B Warrants, the Company offered to those Series B Warrant holders
'/>"/>

SOURCE Ohr Pharmaceutical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia
2. Shimadzu's New DSC-60 Plus Series Differential Scanning Calorimeters Offer High-Sensitivity Analysis in Polymer, Food and Pharmaceutical Applications
3. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
4. PharmaDirections Celebrates 10 Years of Success for Their Virtual Biotech and Pharmaceutical Clients
5. North American Nuclear Medicine / Radiopharmaceutical Market Worth $5.55 Billion by 2017
6. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
7. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
8. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
9. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
10. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... TORONTO , Sept. 22, 2014 ... announced that it has entered into a collaboration ... UHN,s Centre for Molecular Design and Preformulations (CMDP) ... The goal of the project is to increase ... proprietary buccal insulin spray product, thereby reducing the ...
(Date:9/22/2014)... METTLER TOLEDO is pleased to ... device CNS110 ScanTape™ . Replacing a traditional ... greater ease and accuracy for transport and logistics ... enhance productivity—an important benefit for load planning and ... profits. , Usable at any point in ...
(Date:9/21/2014)... 2014 Chemical Sciences play a ... as clean air and safe water, healthy food, ... Chemists, environmentalists, food scientists, educators, and scientists have ... the field of Chemistry for the national development, ... one of the fastest emerging Sciences, accelerating with ...
(Date:9/19/2014)... simple. From crop yields to disease risks, the biological ... "complex traits." Just as for heightthe textbook example of ... disease are shaped by multiple genetic and environmental influences, ... track down such genes, geneticists typically mate two individuals ... and a small mouseand then study their descendents, looking ...
Breaking Biology Technology:Generex Collaborates with University Health Network for Buccal Insulin Project 2Generex Collaborates with University Health Network for Buccal Insulin Project 3Generex Collaborates with University Health Network for Buccal Insulin Project 4ScanTape™ Handheld Dimensioner Increases Processing Volume 2Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3Want to link genes to complex traits? Start with more diversity 2
... fields and tiny iron-bearing particles to drive healthy cells ... in animals, may lead to a new method of ... organs in people. , The study team, led by ... of Pediatric Cardiology at The Childrens Hospital of Philadelphia, ...
... ALTO, Calif., Jan. 7 Telik, Inc. (Nasdaq: ... overview at the,26th Annual JPMorgan Healthcare Conference in San ... Pacific time (10:30 a.m. Eastern,time). A live and archived ... website, http://www.telik.com ., Telik, Inc. of Palo ...
... Potential Blockbuster Product for High Risk Cardiovascular ... ... Calif., Jan. 7 ,Genzyme Corp. (Nasdaq: GENZ ) and Isis ... a major strategic alliance in which,Genzyme will develop and commercialize mipomersen, ...
Cached Biology Technology:Researchers use magnetism to target cells to animal arteries 2Researchers use magnetism to target cells to animal arteries 3Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen 2Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen 3Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen 4Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen 5Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen 6Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen 7
(Date:9/22/2014)... 22, 2014)The Brain & Behavior Research Foundation ... NARSAD Young Investigator Grants valued at more ... world,s most promising young scientists. Recipients of ... research will seek to identify causes, improve ... disorders that affect one in four people, ...
(Date:9/22/2014)... homes, if they could locate people, places and objects. ... lasers, which have difficulty reliably recognizing things and can ... way robots can "sense" what is around them is ... (UHF RFID) tags. Inexpensive self-adhesive tags can be stuck ... room for the correct tag,s signal, even when the ...
(Date:9/22/2014)... warming, larger and larger areas of sea ice melt in ... the winter it is thinner and more reduced. As the ... of global warming, because reduced sea ice in the Arctic ... , "If our results are representative, then sea ice plays ... into account in future global CO2 budgets", says Dorte Haubjerg ...
Breaking Biology News(10 mins):Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3Arctic sea ice helps remove CO2 from the atmosphere 2
... This news release is available in German . ... as popular as jogging. About ten million people in Germany are ... to reduce stress, lose ex- cess fat, and improve endurance. Running ... despite its numerous positive effects, jogging is a desirable sport with ...
... The Bahamas spanning almost two decades shows that female lemon ... give birth to their own young, confirming this behavior for ... and has resulted in the capture, tagging, and release of ... This article, published online on December 5 in ...
... Duke-NUS Graduate Medical School, which form Singapore,s largest academic ... to accelerate the discovery of treatments and cures. They ... Eureka Institute for Translational Medicine today. As ... and Duke-NUS join an elite group of academic medical ...
Cached Biology News:High-tech athletic shoe for pure running pleasure 2New finding shows that mother sharks 'home' to their birthplace to give birth, like salmon and sea turtles 2New finding shows that mother sharks 'home' to their birthplace to give birth, like salmon and sea turtles 3Singapore joins global translational medicine network as Asia-Pacific hub 2Singapore joins global translational medicine network as Asia-Pacific hub 3
... CellBIND surface is produced by a ... more hydrophilic surface giving more consistent, ... and yields. CellBIND enhances cell attachment ... reduced serum or serum-free medium. • ...
iNOS/NOS Type II Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 150 µg Consult technical datasheet for details....
... The Bio-Plex suspension array system, 100-240 ... technology) for simultaneous quantitative analysis of up ... single microplate well. The suspension array is ... sets, each of which may be conjugated ...
... high-throughput fluidics (HTF) system, 100-240 V, is ... array system that automates delivery of up ... the Bio-Plex array reader. The HTF system ... bulk sheath container to constantly maintain a ...
Biology Products: